Gainers
- MAIA Biotechnology, Inc. (NASDAQ:MAIA) rose 37.9% to $8.00 in pre-market trading after jumping 30% on Friday. The company agreed to initially offer 2.00 million shares to the public at a $5.00 per share.
- Aethlon Medical, Inc. (NASDAQ:AEMD) rose 33% to $1.33 in pre-market trading after dropping over 7% on Friday.
- GeoVax Labs, Inc. (NASDAQ:GOVX) rose 32.2% to $3.61 in pre-market trading amid continued strength in monkeypox names. The company also recently announced the publication of a peer-reviewed animal efficacy study of its modified vaccine Ankara vectored vaccine against Sudan ebolavirus.
- Celyad Oncology SA (NASDAQ:CYAD) rose 31.5% to $2.29 in pre-market trading after the company said that the FDA has lifted the clinical hold on the CYAD-101-002 (KEYNOTE-B79) Phase 1b trial.
- Mobile Global Esports Inc. (NASDAQ:MGAM) rose 31.1% to $14.67 in pre-market trading after jumping around 180% on Friday. Mobile Global Esports priced its IPO at $4 per share.
- AIM ImmunoTech Inc. (NYSE:AIM) rose 23.3% to $0.90 in pre-market trading. AIM ImmunoTech, last week, reported positive pilot study data from expanded access program evaluating ampligen for the treatment of long COVID-19.
- Lottery.com Inc. (NASDAQ:LTRY) rose 20.8% to $0.3565 in pre-market trading. Lottery.com shares tumbled around 64% on Friday after the company in an SEC filing said its board determined it does not have sufficient financial resources to fund operations.
- Virax Biolabs Group Limited (NASDAQ:VRAX) rose 19.3% to $6.44 in pre-market trading after declining 74% on Friday.
- Athersys, Inc. (NASDAQ:ATHX) rose 18.7% to $0.2958 in pre-market trading. Athersys is expected to release its Q2 financial results on Thursday, August 11, 2022.
- MediaCo Holding Inc. (NASDAQ:MDIA) rose 15% to $2.36 in pre-market trading. MediaCo Holding) 10% owner Soohyung Kim bought a total of 12,899,480 shares at an average price of $2.32.
- Redbox Entertainment Inc. (NASDAQ:RDBX) rose 14.9% to $5.01 in pre-market trading after declining around 15% on Friday.
- Orchard Therapeutics plc (NASDAQ:ORTX) rose 14.5% to $0.6068 in pre-market trading after declining around 4% on Friday.
- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) shares rose 13.4% to $0.8990 in pre-market trading after jumping over 51% on Friday. The U.S. Food and Drug Administration, last month, declined to issue an Emergency Use Authorization (EUA) for NRx Pharmaceuticals’ lead drug ZYESAMI (aviptadil) for subgroup of patients with critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir.
- 36Kr Holdings Inc. (NASDAQ:KRKR) rose 11.3% to $1.28 in pre-market trading after gaining more than 9% on Friday.
- TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ) rose 10.9% to $0.9650 in pre-market trading after dropping over 9% on Friday.
- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) rose 10.1% to $1.85 in pre-market trading after dropping 10% on Friday. Tonix Pharmaceuticals recently announced a collaboration with the Kenya Medical Research Institute to plan, seek regulatory approval for and conduct a Phase 1 clinical study to develop TNX-801 as a vaccine to protect against monkeypox and smallpox.
- SIGA Technologies, Inc. (NASDAQ:SIGA) rose 9.7% to $18.86 in pre-market trading. SIGA Technologies shares dropped sharply on Friday after the FDA announced there is currently no human data demonstrating the efficacy of Tpoxx for the treatment of Monkeypox.
- Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) rose 9.5% to $0.81 in pre-market trading. Creative Medical Technology recently reported positive top-line results for OvaStem® pilot study.
- Statera Biopharma, Inc. (NASDAQ:STAB) rose 9.2% to $0.2290 in pre-market trading.
- Fathom Digital Manufacturing Corporation (NYSE:FATH) rose 7.5% to $4.60 in pre-market trading.
